Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
David A Moore
Affiliation
University College London Cancer Institute
ORCID
Career Start Year
2012
Papers
37
H Index
15
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
37258251
Landscape of cancer biomarker testing in England following genomic services reconfiguration: insights from a nationwide pathologist survey.
J Clin Pathol
2024
36853169
Spatial Positioning of Immune Hotspots Reflects the Interplay between B and T Cells in Lung Squamous Cell Carcinoma.
Cancer Res
2023
37608772
Pitfalls in machine learning-based assessment of tumor-infiltrating lymphocytes in breast cancer: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer
J Pathol
2023
37608771
Spatial analyses of immune cell infiltration in cancer: current methods and future directions: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer.
J Pathol
2023
37342197
Phenotyping of lymphoproliferative tumours generated in xenografts of non-small cell lung cancer.
Front Oncol
2023
36977461
Late-Stage Metastatic Melanoma Emerges through a Diversity of Evolutionary Pathways.
Cancer Discov
2023
34168072
Prevalence and breakdown of EGFR exon 20 driver mutations in routine NHS lung cancer diagnostic testing.
J Clin Pathol
2022
35912165
Diagnosis and Clinical Management of Chagas Disease: An Increasing Challenge in Non-Endemic Areas.
Res Rep Trop Med
2022
36291791
Comparative Evaluation of Tumor-Infiltrating Lymphocytes in Companion Animals: Immuno-Oncology as a Relevant Translational Model for Cancer Therapy.
Cancers (Basel)
2022
36156323
Prevalence and breakdown of non-small cell lung cancer BRAF driver mutations in a large UK cohort.
Lung Cancer
2022
35091446
Expanding Therapeutic Opportunities for Extrapulmonary Neuroendocrine Carcinoma.
Clin Cancer Res
2022
33155719
Inclusion of multiple high-risk histopathological criteria improves the prediction of adjuvant chemotherapy efficacy in lung adenocarcinoma.
Histopathology
2021
33795785
Transcriptional perturbation of protein arginine methyltransferase-5 exhibits MTAP-selective oncosuppression.
Sci Rep
2021
34489586
Large cell neuroendocrine lung carcinoma: consensus statement from The British Thoracic Oncology Group and the Association of Pulmonary Pathologists.
Br J Cancer
2021
34536732
Optimising fusion detection through sequential DNA and RNA molecular profiling of non-small cell lung cancer.
Lung Cancer
2021
32129476
The path to a better biomarker: application of a risk management framework for the implementation of PD-L1 and TILs as immuno-oncology biomarkers in breast cancer clinical trials and daily practice.
J Pathol
2020
32879494
Pervasive chromosomal instability and karyotype order in tumour evolution.
Nature
2020
30992300
Personalized Detection of Circulating Tumor DNA Antedates Breast Cancer Metastatic Recurrence.
Clin Cancer Res
2019
31245058
Prospective analysis of 895 patients on a UK Genomics Review Board.
ESMO Open
2019
30932019
In situ growth in early lung adenocarcinoma may represent precursor growth or invasive clone outgrowth-a clinically relevant distinction.
Mod Pathol
2019
29113995
Time for change: a new training programme for morpho-molecular pathologists?
J Clin Pathol
2018
30054375
Analysis of a large cohort of non-small cell lung cancers submitted for somatic variant analysis demonstrates that targeted next-generation sequencing is fit for purpose as a molecular diagnostic assay in routine practice.
J Clin Pathol
2018
30076358
Genomic instability in mutant p53 cancer cells upon entotic engulfment.
Nat Commun
2018
30154405
Publisher Correction: Genomic instability in mutant p53 cancer cells upon entotic engulfment.
Nat Commun
2018
30108309
Sensitivity of Colorectal Cancer to Arginine Deprivation Therapy is Shaped by Differential Expression of Urea Cycle Enzymes.
Sci Rep
2018
29535826
Circulating tumour-derived DNA in metastatic soft tissue sarcoma.
Oncotarget
2018
29258292
Corrigendum: Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution.
Nature
2018
29152076
Profiling tumour heterogeneity through circulating tumour DNA in patients with pancreatic cancer.
Oncotarget
2017
28445469
Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution.
Nature
2017
28445112
Tracking the Evolution of Non-Small-Cell Lung Cancer.
N Engl J Med
2017
28202521
<i>Ex Vivo</i> Explant Cultures of Non-Small Cell Lung Carcinoma Enable Evaluation of Primary Tumor Responses to Anticancer Therapy.
Cancer Res
2017
26369632
SRC3 Phosphorylation at Serine 543 Is a Positive Independent Prognostic Factor in ER-Positive Breast Cancer.
Clin Cancer Res
2016
25959953
The molecular approach to diagnosis in lung cancer.
Br J Hosp Med (Lond)
2015
26134170
Duplex Ratio Tests as Diagnostic Biomarkers in Malignant Melanoma.
J Mol Diagn
2015
25141981
Phosphorylation of activating transcription factor-2 (ATF-2) within the activation domain is a key determinant of sensitivity to tamoxifen in breast cancer.
Breast Cancer Res Treat
2014
23810241
Accurate detection of copy number changes in DNA extracted from formalin-fixed, paraffin-embedded melanoma tissue using duplex ratio tests.
J Mol Diagn
2013
21880059
Prognostic tissue markers in melanoma.
Histopathology
2012
1 - 37 of 37
Column Actions
Search
Recommended Authors
Daniel Kazdal
Institut fur Pathologie, Universitatsklinikum Heidelberg
Career Start Year
2016
Number of shared co-authors
3
Philipp Jurmeister
Institute of Pathology, Ludwig-Maximilians-Universitat Munchen
Career Start Year
2015
Number of shared co-authors
2
Jason D Peterson
Geisel School of Medicine at Dartmouth, Dartmouth-Hitchcock Medical Center
Career Start Year
2014
Number of shared co-authors
0
Jianjun Zhang
The University of Texas MD Anderson Cancer Center
Career Start Year
2012
Number of shared co-authors
7
Yang Shao
Nanjing Geneseeq Technology Inc.
Career Start Year
2012
Number of shared co-authors
1
Arshi Arora
Memorial Sloan Kettering Cancer Center
Career Start Year
2011
Number of shared co-authors
0
Siddhartha Devarakonda
Siteman Cancer Center, Washington University School of Medicine
Career Start Year
2011
Number of shared co-authors
0
Charlotte K Y Ng
University of Bern
Career Start Year
2009
Number of shared co-authors
6
Eliezer M Van Allen
Dana-Farber Cancer Institute
Career Start Year
2009
Number of shared co-authors
4
Ashiq Masood
Indiana University Melvin and Bren Simon Comprehensive Cancer Center
Career Start Year
2008
Number of shared co-authors
0
Oscar Krijgsman
The Netherlands Cancer Institute
Career Start Year
2008
Number of shared co-authors
3
Francine B de Abreu
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year
2007
Number of shared co-authors
0
Martina Kirchner
Institute of Pathology, University Hospital Heidelberg
Career Start Year
2007
Number of shared co-authors
2
Nicola Waddell
QIMR Berghofer Medical Research Institute
Career Start Year
2006
Number of shared co-authors
8
Marzena Walkiewicz
Olivia Newton-John Cancer Research Institute
Career Start Year
2003
Number of shared co-authors
3
Trevor J Pugh
Princess Margaret Cancer Centre, University Health Network
Career Start Year
2003
Number of shared co-authors
2
Debyani Chakravarty
Memorial Sloan Kettering Cancer Center
Career Start Year
2002
Number of shared co-authors
4
Frederick Klauschen
Institute of Pathology, Ludwig-Maximilians-Universitat Munchen
Career Start Year
2002
Number of shared co-authors
8
Olaf Neumann
Institute of Pathology, University Hospital Heidelberg
Career Start Year
2002
Number of shared co-authors
2
Volker Endris
Institute of Pathology, University Hospital Heidelberg
Career Start Year
2001
Number of shared co-authors
4
Luciano G Martelotto
Monash University
Career Start Year
2000
Number of shared co-authors
3
Andrea Sboner
Institute for Computational Biomedicine
Career Start Year
2000
Number of shared co-authors
3
David Neil Hayes
Center for Cancer Research, University of Tennessee Health Science Center
Career Start Year
1999
Number of shared co-authors
2
Kenna R Mills Shaw
The University of Texas MD Anderson Cancer Center
Career Start Year
1999
Number of shared co-authors
2
Prudence A Russell
St Vincent's Hospital
Career Start Year
1997
Number of shared co-authors
7
Anthony J Iafrate
Massachusetts General Hospital
Career Start Year
1997
Number of shared co-authors
5
Jan Budczies
Institute of Pathology, University Hospital Heidelberg
Career Start Year
1996
Number of shared co-authors
7
Siraj M Ali
Foundation Medicine
Career Start Year
1995
Number of shared co-authors
2
Marc Ladanyi
Memorial Sloan Kettering Cancer Center
Career Start Year
1984
Number of shared co-authors
4
Matthew Meyerson
Broad Institute
Career Start Year
1983
Number of shared co-authors
4
row(s) 1 - 30 of 30
Collaborators
John Le Quesne
Beatson Cancer Research Institute, University of Glasgow
Co-authored papers
12
Charles Swanton
Francis Crick Institute
Co-authored papers
10
Dean A Fennell
University of Leicester
Co-authored papers
5
Apostolos Nakas
University Hospitals of Leicester NHS Trust
Co-authored papers
5
Peter Van Loo
The Francis Crick Institute
Co-authored papers
4
Fiona Blackhall
The University of Manchester
Co-authored papers
4
Jin-Li Luo
University of Leicester
Co-authored papers
4
Wei Yang
Co-authored papers
3
Christos Sotiriou
Co-authored papers
3
Stephen M Hewitt
Center for Cancer Research, National Cancer Institute
Co-authored papers
3
Sandra Demaria
Weill Cornell Medical College
Co-authored papers
3
John M S Bartlett
University of Edinburgh
Co-authored papers
3
William F Symmans
Co-authored papers
3
David L Rimm
Yale University School of Medicine
Co-authored papers
3
Paula I Gonzalez-Ericsson
Co-authored papers
3
Jorge S Reis-Filho
Memorial Sloan-Kettering Cancer Center
Co-authored papers
2
Stefan C Dentro
Wellcome Sanger Institute
Co-authored papers
2
Carolyn Jones
University of Cambridge
Co-authored papers
2
Wilbert Zwart
Oncode Institute, The Netherlands Cancer Institute
Co-authored papers
2
Sacha Gnjatic
The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
Co-authored papers
2
Joel Saltz
Stony Brook University
Co-authored papers
2
Jeroen A W M van der Laak
Radboud University Medical Center
Co-authored papers
2
Albrecht Stenzinger
Institute of Pathology, University Hospital Heidelberg
Co-authored papers
2
Michael Vieth
Institute of Pathology, Friedrich-Alexander-University Erlangen-Nuremberg
Co-authored papers
2
William M Gallagher
All-Island Cancer Research Institute, UCD Conway Institute, University College Dublin
Co-authored papers
2
Hannah Y Wen
Memorial Sloan Kettering Cancer Center
Co-authored papers
2
Paul J van Diest
University Medical Center Utrecht
Co-authored papers
2
Jochen K Lennerz
Massachusetts General Hospital/Harvard Medical School
Co-authored papers
2
Thomas Walter
PSL University
Co-authored papers
2
Lajos Pusztai
Co-authored papers
2
1 - 30